We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $23.2B
1-Year Est. Return 40.19%
This Fund
S&P 500
This Quarter Est. Return
-14.21%
1 Year Est. Return
+40.19%
3 Year Est. Return
+109.35%
5 Year Est. Return
+140.11%
10 Year Est. Return
+481.97%
AUM
$89.1B
AUM Growth
-$42.4B
Cap. Flow
-$3.95B
Cap. Flow %
-4.44%
Top 10 Hldgs %
11.59%
Holding
2,672
New
86
Increased
706
Reduced
853
Closed
108

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$504M
2
AAPL icon
Apple
AAPL
+$433M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$248M
4
VTRS icon
Viatris
VTRS
+$241M
5
AMZN icon
Amazon
AMZN
+$210M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.43%
3 Financials 13.99%
4 Industrials 10.31%
5 Consumer Discretionary 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCUL icon
2551
Ocular Therapeutix
OCUL
$2.34B
-8,837
Closed -$44K
OMER icon
2552
Omeros
OMER
$1.37B
-4,909
Closed -$30K
ORGO icon
2553
Organogenesis Holdings
ORGO
$220M
$0 ﹤0.01%
62
ORIC icon
2554
Oric Pharmaceuticals
ORIC
$1.33B
-354
Closed -$2K
PACK icon
2555
Ranpak Holdings
PACK
$389M
-1,217
Closed -$25K
PASG icon
2556
Passage Bio
PASG
$15M
-13
Closed -$1K
PAX icon
2557
Patria Investments
PAX
$1.8B
-801,815
Closed -$14.3M
PSCE icon
2558
Invesco S&P SmallCap Energy ETF
PSCE
$111M
-362,000
Closed -$18.1M
PSNL icon
2559
Personalis
PSNL
$1.84B
-1,395
Closed -$11K
QGEN icon
2560
Qiagen
QGEN
$8.98B
-94
Closed -$5K
QNCX icon
2561
Quince Therapeutics
QNCX
$31.9M
-2
Closed -$3K
QVMS
2562
Invesco S&P SmallCap 600 QVM Multi-factor ETF
QVMS
$250M
-10,000
Closed -$243K
REKR icon
2563
Rekor Systems
REKR
$73.8M
-7,378
Closed -$34K
SG icon
2564
Sweetgreen
SG
$814M
-122,431
Closed -$3.92M
SHYF
2565
DELISTED
The Shyft Group
SHYF
-1,223
Closed -$44K
SKYT
2566
DELISTED
SkyWater Technology
SKYT
-704,000
Closed -$7.62M
SMWB icon
2567
Similarweb
SMWB
$780M
-398,165
Closed -$5.16M
TCRT icon
2568
Alaunos Therapeutics
TCRT
$4.14M
-187
Closed -$18K
TOST icon
2569
Toast
TOST
$19.6B
-4,618
Closed -$100K
TRP icon
2570
TC Energy
TRP
$65.2B
-14,279
Closed -$807K
TSHA icon
2571
Taysha Gene Therapies
TSHA
$1.82B
-867
Closed -$6K
UL icon
2572
Unilever
UL
$138B
-140
Closed -$7K
UMC icon
2573
United Microelectronic
UMC
$52.1B
-24,806
Closed -$226K
URGN icon
2574
UroGen Pharma
URGN
$2.16B
-959
Closed -$8K
VONG icon
2575
Vanguard Russell 1000 Growth ETF
VONG
$46.2B
-10,910
Closed -$779K

Similar funds

Macquarie Group's Q2 2022 Portfolio in Review

As of Q2 2022, Macquarie Group held 2,672 positions worth $89.1B, down 32% from $131B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Macquarie Group withdrew a net $3.95B in Q2 2022, closing 108 positions and reducing 853 holdings. Its most notable exit was ASPEN TECHNOLOGY INC, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in Petco worth $56.3M.

  • Macquarie Group's largest Q2 2022 buy was Petco: 3,818,489 shares worth $56.3M.
  • Macquarie Group added most to Hologic in Q2 2022, an estimated $324M increase.
  • Macquarie Group's biggest Q2 2022 reduction was Microsoft, cutting an estimated $504M.
  • Macquarie Group fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $149M.
  • Macquarie Group's ten largest holdings make up 12% of its $89.1B portfolio in Q2 2022.
  • Macquarie Group opened 86 new positions and closed 108 in Q2 2022.
  • Macquarie Group's portfolio value fell 32% quarter-over-quarter to $89.1B.

Based on Macquarie Group's 13F filing for Q2 2022, filed 15 Aug 2022.